European equities traded in the US as American depositary receipts were moving lower late Wednesday morning, declining 0.57% to 1,400.52 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by furniture maker Natuzzi (NTZ) and internet advertising firm Criteo (CRTO), which climbed 7.3% and 2.4% respectively. They were followed by biopharmaceutical company Grifols (GRFS) and pharmaceutical company Novo Nordisk (NVO), which increased 1.6% and 1% respectively.
The decliners from continental Europe were led by electronics conglomerate Philips (PHG) and semiconductor company Sequans Communications (SQNS), which dropped 12% and 3.1% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and biotech firm BioNTech (BNTX), which lost 2.7% and 2.5% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics (AKTX) and biotech firm Autolus Therapeutics (AUTL), which rose 4.5% and 1.7% respectively. They were followed by utilities company National Grid (NGG) and oil and gas company Shell (SHEL), which were up 0.6% and 0.4% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company TC Biopharm (TCBP) and software firm Endava (DAVA), which fell 6.7% and 6.3% respectively. They were followed by construction materials supplier CRH (CRH) and insurance company Prudential (PUK), which were down 3.6% and 2.9% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。